Can you provide the last earnings date for PHIO PHARMACEUTICALS CORP?
PHIO PHARMACEUTICALS CORP (PHIO) last reported earnings on 3/5/2026.
PHIO PHARMACEUTICALS CORP (PHIO) Earnings History & Surprises
NASDAQ:PHIO • US71880W5013
Current stock price
1.22 USD
+0.04 (+3.39%)
At close:
1.2 USD
-0.02 (-1.64%)
After Hours:
PHIO Earnings overview
Past quarterly earnings results for PHIO PHARMACEUTICALS CORP (PHIO), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- May 13, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.24
- Revenue Estimate
Last Reported
Most Recent- Release Date
- Mar 5, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.25
- EPS Surprise
- 27.05%
- Revenue Surprise
- %
Beat Rate
Last 8 Quarters 0%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.25 | -0.35 | 27.05% | 70.24% | - | - | ||
| Q3 2025 | -0.44 | -0.46 | 4.14% | 71.43% | - | - | ||
| Q2 2025 | -0.45 | -0.37 | -22.55% | 87.57% | - | - | ||
| Q1 2025 | - | - | - | - | ||||
| Q4 2024 | -0.85 | -1.25 | 32.25% | 88.89% | - | - | ||
| Q3 2024 | -1.54 | -4.22 | 63.53% | 84.99% | - | - | ||
| Q2 2024 | -3.62 | -4.68 | 22.68% | - | - | - | ||
| Q1 2024 | -0.47 | - | - | - | - | |||
| Q4 2023 | -7.65 | -11.93 | 35.90% | 64.58% | - | - | ||
| Q3 2023 | -10.26 | -13.13 | 21.84% | 63.46% | - | - | ||
| Q2 2023 | - | - | - | - | ||||
| Q1 2023 | - | - | - | - | ||||
| Q4 2022 | -21.60 | -29.74 | 27.38% | 25.93% | - | - | ||
| Q3 2022 | -28.08 | 39.66 | -170.81% | 7.14% | 12.75M | -100.00% | - | |
| Q2 2022 | -20.52 | -34.15 | 39.91% | 5.00% | - | - | ||
| Q1 2022 | -20.52 | -33.05 | 37.91% | -5,935.29% | - | - | ||
| Q4 2021 | -29.16 | -35.25 | 17.28% | 34.15% | - | - | ||
| Q3 2021 | -30.24 | -27.54 | -9.80% | 30.00% | - | - | ||
| Q2 2021 | -21.60 | -28.64 | 24.59% | 41.18% | - | - | ||
| Q1 2021 | -0.34 | - | - | - | - | |||
| Q4 2020 | -44.28 | -46.27 | 4.30% | - | - | - | ||
| Q3 2020 | -43.20 | -41.31 | -4.58% | - | - | - | ||
| Q2 2020 | -36.72 | -71.05 | 48.32% | - | - | - | ||
| Q1 2020 | - | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
N/A
Average EPS beat (4)
N/A
Max EPS beat (4)
N/A
Min EPS beat (4)
N/A
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
Related analysis
PHIO PHARMACEUTICALS CORP / PHIO Earnings FAQ
Did PHIO stock beat earnings estimates in the most recent quarter?
PHIO PHARMACEUTICALS CORP (PHIO) beat EPS estimates and missed revenue estimates in the most recent quarter.